CN Patent

CN1735459A — 氢化催化剂

Assigned to UCB SA · Expires 2006-02-15 · 20y expired

What this patent protects

一种包含固定在特定沸石载体上的手性过渡金属－(1，2－二(2，5－二烷基磷杂环戊基)苯)配合物的催化剂，用于前手性基质的氢化。

USPTO Abstract

一种包含固定在特定沸石载体上的手性过渡金属－(1，2－二(2，5－二烷基磷杂环戊基)苯)配合物的催化剂，用于前手性基质的氢化。

Drugs covered by this patent

Briviact (BRIVARACETAM) · UCB

Patent Metadata

Patent number: CN1735459A
Jurisdiction: CN
Classification: —
Expires: 2006-02-15
Drug substance claim: No
Drug product claim: No
Assignee: UCB SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.